HealthTech
Helex Raises $3.5 Mn To Develop Targeted Medicines For Genetic Kidney Diseases
[ad_1]
SUMMARY
The seed funding round was led by pi Ventures, with participation from a host of investors, including Bluehill.VC, US-based SOSV, among others
The startup will deploy the capital to accelerate pre-clinical development of its lead programme —- developing a drug to cure patients suffering from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Founded in 2021, Helex is developing advanced medicines for curing genetic kidney diseases via gene and cell therapy
Biotech startup Helex
has raised $3.5 Mn (around INR…
[ad_2]
Source link
Continue Reading